Tavolixizumab
Tavolixizumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Tavolixizumab is under investigation in clinical trial NCT02318394 (A Phase 1 Study of MEDI0562 in Adult Subjects With Selected Advanced Solid Tumors).
| Trade Name | Tavolixizumab |
| Generic | Tavolixizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Tavolixizumab
